Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Biological Therapy Analysis & Statistics, July 2012 (p9)

You might be interested in: stem cell, cell therapy, tissue engineering, more »

» Purchase Premium Reports

241-270 of about 400 reports
Natural Killer Cell Lymphomas - Pipeline Review, H2 2012

Natural Killer Cell Lymphomas - Pipeline Review, H2 2012

  • $ 500
  • Company report
  • July 2012
  • by Global Markets Direct

Natural Killer Cell Lymphomas - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Natural Killer Cell Lymphomas - Pipeline Review, H2 2012', provides an overview of the Natural Killer Cell ...

  • Industries : Biological Therapy
  • Countries : United States, World
Market and Product Forecasts: Targeted Cancer Therapies 2011-21 -  Eurozone price cuts impact targeted cancer therapies market

Market and Product Forecasts: Targeted Cancer Therapies 2011-21 - Eurozone price cuts impact targeted cancer therapies market

  • $ 11 400
  • Industry report
  • July 2012
  • by Datamonitor

The targeted therapies class has fueled most of the recent rapid growth of the oncology market as a whole. In the next decade the market will become more fragmented as new targeted therapies are developed ...

  • Industries : Biological Therapy
  • Countries : Europe, United States, Japan, Spain, Italy, France, Germany, World, United Kingdom
Global Markets for Stem Cells

Global Markets for Stem Cells

  • $ 6 650
  • Industry report
  • July 2012
  • by BCC Research

INTRODUCTION STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription drug products. ...

  • Industries : Biological Therapy
  • Countries : World
Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (600645) - Company Capsule

Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (600645) - Company Capsule

  • $ 75
  • Company report
  • July 2012
  • by World Market Intelligence Ltd

Synopsis WMI's 'Zhongyuan Union Stem Cell Bioengineering Co., Ltd. (600645) - Company Capsule' contains a company overview, key facts, key employees, products and services, key competitors as well as financial ...

  • Industries : Biological Therapy
Global Human Embryonic Stem Cell (hESC) Research Industry

Global Human Embryonic Stem Cell (hESC) Research Industry

  • $ 3 450
  • Industry report
  • July 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual ...

  • Industries : Biological Therapy
  • Countries : United States, World
Survey: 7 Things You Need to Know to Profit from Feeder-Free Culture

Survey: 7 Things You Need to Know to Profit from Feeder-Free Culture

  • $ 177
  • Industry report
  • July 2012
  • by BioInformant Worldwide, L.L.C.

Following a series of requests from our clients to explore the topic of feeder-dependent versus feeder-free culture using our Scientist Panel, we completed a survey on this topic. The key findings are ...

  • Industries : Biological Therapy
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) ...

  • Industries : Biological Therapy
  • Countries : World, United States
Alpha-Mannosidosis - Pipeline Review, H1 2012

Alpha-Mannosidosis - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • June 2012
  • by Global Markets Direct

Alpha-Mannosidosis - Pipeline Review, H1 2012 Summary Global Markets Direct's, 'Alpha-Mannosidosis - Pipeline Review, H1 2012', provides an overview of the Alpha-Mannosidosis therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards Summary GBI Research's new report, ?Gene Therapy Market to ...

  • Industries : Biological Therapy
  • Countries : World
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

  • $ 3 500
  • Industry report
  • June 2012
  • by GBI Research

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications Summary GBI Research, the leading business intelligence ...

  • Industries : Biological Therapy
  • Countries : World
Competitor Analysis: Immunotherapy of Alzheimer`s Disease

Competitor Analysis: Immunotherapy of Alzheimer`s Disease

  • $ 528
  • Industry report
  • May 2012
  • by La Merie Publishing

Competitor Analysis: Immunotherapy of Alzheimer's Disease The Competitive Intelligence Report Immunotherapy of Alzheimer's Disease as of May 2012 provides a competitor analysis in the development pipeline ...

  • Industries : Biological Therapy
ProStrakan Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

ProStrakan Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2012
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Global Stem Cell Research Industry

Global Stem Cell Research Industry

  • $ 4 500
  • Industry report
  • May 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Stem Cell Research in US$ Million. Annual estimates and forecasts are provided for the period 2008 through 2017. The report provides separate comprehensive ...

  • Industries : Biological Therapy
  • Countries : World, United States
Fibrocell Sciences, Inc. (Symbol:ILEIQ) SWOT Analysis, Strategy, Revenues and Profits

Fibrocell Sciences, Inc. (Symbol:ILEIQ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Global Growth Factors (Blood And Tissue) Industry

Global Growth Factors (Blood And Tissue) Industry

  • $ 4 500
  • Industry report
  • May 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Growth Factor Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, ...

  • Industries : Biological Therapy
  • Countries : World, United States, Japan, Europe
Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, H1 2012

Biological Therapy Industry: Plasma Cell Neoplasm - Pipeline Review, H1 2012

  • $ 500
  • Company report
  • April 2012
  • by Global Markets Direct

This report provides data on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

  • Industries : Biological Therapy
Global RNA Interference (RNAi) Industry

Global RNA Interference (RNAi) Industry

  • $ 4 800
  • Industry report
  • April 2012
  • by Global Industry Analyst

This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target Validation, Reagents, and siRNA Synthesis. The report ...

  • Industries : Biological Therapy
  • Countries : World
Human Stem Cell Banks in the US - Industry Market Research Report

Human Stem Cell Banks in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • April 2012
  • by Ibisworld

Human Stem Cell Banks Human stem cell banks collect, test, preserve and deliver stem cells from donors either for preparation of cell lines for use in research, or for future use through banking umbilical ...

  • Industries : Biological Therapy
  • Countries : United States
Global RNAi Market Analysis

Global RNAi Market Analysis

  • $ 1 200
  • Industry report
  • April 2012
  • by RNCOS

RNA Interference (RNAi) has emerged as a breakthrough in the life sciences industry. It presents an extensive potential in multiple areas, such as drug discovery, drug development, and therapeutic applications ...

  • Industries : Biological Therapy
  • Countries : World
Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (SYMD) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial company principally engaged in the development and distribution of anti-adhesion surgical products. ...

  • Industries : Biological Therapy
  • Countries : United States
Stem Cell Sciences Plc (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

Stem Cell Sciences Plc (Symbol:STEM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
Stem Cell Innovations, Inc. (Symbol:SCLL) SWOT Analysis, Strategy, Revenues and Profits

Stem Cell Innovations, Inc. (Symbol:SCLL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Chemokine Therapeutics Corp. (Symbol:CTI) SWOT Analysis, Strategy, Revenues and Profits

Chemokine Therapeutics Corp. (Symbol:CTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Canada, United Kingdom
Genitope Corporation (Symbol:GTOP) SWOT Analysis, Strategy, Revenues and Profits

Genitope Corporation (Symbol:GTOP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Biologics Market in Brazil

Biologics Market in Brazil

  • $ 6 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

This research service considers the biologics market in Brazil. It covers the market's move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, ...

  • Industries : Biological Therapy
  • Countries : Brazil
Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Fibrocell Sciences, Inc. (ILEIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Fibrocell Sciences, Inc. (Fibrocell), formerly Isolagen, Inc., is an aesthetic and therapeutic development ...

  • Industries : Biological Therapy
  • Countries : United States
Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile

Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

Pathfinder Cell Therapy, Inc. (SYMD) - Medical Equipment - Deals and Alliances Profile Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy), formerly known as SyntheMed, Inc., is a biomaterial ...

  • Industries : Biological Therapy
Global Gene Therapy Industry

Global Gene Therapy Industry

  • $ 4 500
  • Industry report
  • February 2012
  • by Global Industry Analyst

This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through 2017. The report profiles 98 companies including many key ...

  • Industries : Biological Therapy
  • Countries : World
Global Tissue Engineering and Regeneration Market 2011-2015

Global Tissue Engineering and Regeneration Market 2011-2015

  • $ 1 500
  • Industry report
  • February 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Tissue Engineering and Regeneration market to grow at a CAGR of 8.5 percent over the period 2011-2015. One of the key factors contributing to this market growth ...

  • Industries : Biological Therapy
  • Countries : World
RNA Interference Therapy in Oncology Drug Pipeline Update 2012

RNA Interference Therapy in Oncology Drug Pipeline Update 2012

  • $ 1 499
  • Company report
  • February 2012
  • by Bioseeker

Potentially any disease-causing gene, cell type or tissue can be targeted with RNAi, including those not 'druggable' with small molecules or protein-based therapies. There are today 43 companies plus partners ...

  • Industries : Biological Therapy

» View Public Reports

About 900 reports

Cell Culture Business (cell culture, cell therapy) in Thailand and The United States

  • Industry report
  • March 2014
  • 7 pages
  • by Research Paper

... cultured cells selected for high production of secondary metabolites (dicosmo and misawa, 1995). One way to increase the production level of secondary metabolites is by elicitation, which ...


» Read our Company Profiles

35 Companies

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

Geron Corp.

United States

Celgene Corp.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.